Invention Grant
- Patent Title: Antigens and epitopes derived from Mycobacterium tuberculosis
-
Application No.: US13632281Application Date: 2012-10-01
-
Publication No.: US10703784B2Publication Date: 2020-07-07
- Inventor: Alessandro Sette , Cecilia Arlehamm , Bjoern Peters , Howard Grey , John Sidney
- Applicant: LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY
- Applicant Address: US CA La Jolla
- Assignee: LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY
- Current Assignee: LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY
- Current Assignee Address: US CA La Jolla
- Agency: Pillsbury Winthrop Shaw Pittmann LLP
- Main IPC: A61K39/04
- IPC: A61K39/04 ; A61K39/02 ; A61K39/00 ; C07K14/35 ; A61K45/06
Abstract:
The present invention relates to M. tuberculosis proteins and peptides, and subsequences, portions or modifications thereof and methods and compounds comprising the same for eliciting, stimulating, inducing, promoting, increasing, or enhancing an anti-M. tuberculosis immune response in a subject.
Public/Granted literature
- US20140004151A1 Antigens and Epitopes Derived From Mycobacterium Tuberculosis Public/Granted day:2014-01-02
Information query
